PPI Versus Placebo in Severe Functional Heartburn
Status: Recruiting (N/A). Started on October 1st, 2003.
Enrollment: 60 subjects
Study Type: Interventional
Study Design:
- Treatment
- Randomized
- Double-Blind
- Placebo Control
- Single Group Assignment
- Efficacy Study
Conditions:
Interventions:
- Drug: PPI
Eligibility
Inclusion Criteria:
- Heartburn twice a week for at least 2 years. Normal EGD and 24hr pH study.
Exclusion Criteria:
- Gender
Both
- Mininum Age
18 Years
- Maximum Age
N/A
- Healthy Volunteers
No
Resources
Source: University of Southern California
Authority: United States: Institutional Review Board
Locations
-
USC Keck School of Medicine
LA
California
90033
United States
Officials
Michael M Kline, MD (Principal Investigator, University of Southern California)
Sponsors
University of Southern California (Lead Sponsor)
References
None.
Links
None.
- Date Verified
- September 1st, 2006
- First Received
- September 13th, 2006
- Last Changed
- September 13th, 2006
Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.
All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.
The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.